Cargando…

Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses

Recent advances in cancer immunology have led to a better understanding of the role of the tumor microenvironment (TME) in tumor initiation, progression, and metastasis. Tumors can occur at many locations within the body and coevolution between malignant tumor cells and non-malignant cells sculpts t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliver, Amanda J., Lau, Peter K. H., Unsworth, Ashleigh S., Loi, Sherene, Darcy, Phillip K., Kershaw, Michael H., Slaney, Clare Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797771/ https://www.ncbi.nlm.nih.gov/pubmed/29445373 http://dx.doi.org/10.3389/fimmu.2018.00070

Ejemplares similares

Tissue-specific tumour microenvironments are an emerging determinant of immunotherapy responses
por: Oliver, Amanda J., et al.
Publicado: (2020)

Tissue‐specific tumor microenvironments influence responses to immunotherapies
por: Oliver, Amanda J, et al.
Publicado: (2019)

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
por: Devaud, Christel, et al.
Publicado: (2013)

Primary and metastatic breast tumors cross-talk to influence immunotherapy responses
por: Oliver, Amanda J, et al.
Publicado: (2020)

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
por: Kershaw, Michael H, et al.
Publicado: (2013)

Challenges and Opportunities for Effective Cancer Immunotherapies
por: Slaney, Clare Y., et al.
Publicado: (2020)

Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells
por: Chan, Jack D, et al.
Publicado: (2020)

An ultrastructural investigation of tumors undergoing regression mediated by immunotherapy
por: Westwood, Jennifer A., et al.
Publicado: (2017)

Clinical application of genetically modified T cells in cancer therapy
por: Kershaw, Michael H, et al.
Publicado: (2014)

Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment
por: Van Audenaerde, Jonas RM, et al.
Publicado: (2020)

Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges
por: Pappas, Evan G., et al.
Publicado: (2023)

Vascular Microenvironment, Tumor Immunity and Immunotherapy
por: Lamplugh, Zachary, et al.
Publicado: (2021)

Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)

Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022)

Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities
por: Chan, Jack D., et al.
Publicado: (2020)

Current status, challenges and perspectives: immunotherapy and tumour microenvironment in thoracic cancer
por: Luo, Peng, et al.
Publicado: (2020)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
por: Slaney, Clare Y., et al.
Publicado: (2023)

Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
por: Ngiow, Shin Foong, et al.
Publicado: (2020)

Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses
por: Deng, Ruiyi, et al.
Publicado: (2022)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
por: Zhou, Wencheng, et al.
Publicado: (2022)

Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy
por: Yang, Rou, et al.
Publicado: (2023)

Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
por: Shafqat, Areez, et al.
Publicado: (2023)

Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
por: Shafqat, Areez, et al.
Publicado: (2023)

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing
por: Bai, Rilan, et al.
Publicado: (2022)

The effect of organ-specific tumor microenvironments on response patterns to immunotherapy
por: Conway, Jordan W., et al.
Publicado: (2022)

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies
por: Xu, Jiuhui, et al.
Publicado: (2023)

Ultrasound-Targeted Microbubble Destruction: Modulation in the Tumor Microenvironment and Application in Tumor Immunotherapy
por: Han, Ye, et al.
Publicado: (2022)

Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles
por: Zhang, Mei, et al.
Publicado: (2018)

Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
por: Ben-Shmuel, Aviad, et al.
Publicado: (2020)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
por: Qiu, Qin, et al.
Publicado: (2021)

Erratum: Development of immunotherapy strategies targeting tumor microenvironment is fiercely ongoing
Publicado: (2022)

Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
por: Ye, Zilan, et al.
Publicado: (2022)

The components of tumor microenvironment as biomarker for immunotherapy in metastatic renal cell carcinoma
por: Su, Jiaming, et al.
Publicado: (2023)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
por: Deng, Xinpei, et al.
Publicado: (2023)

Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
por: Albini, Adriana, et al.
Publicado: (2018)

Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy
por: Li, Yiliang, et al.
Publicado: (2018)

Editorial: Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy
por: Chouaib, Salem, et al.
Publicado: (2020)

Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
por: Wennerberg, Erik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d4kgiv18i8mrsp7gofk3i4qcn1